Associated Papers
Disease-Specific and Histological Outcomes of Preoperative TERT Promoter Mutation Detected in Isolation or in Combination with Other Mutations in Thyroid Neoplasms.
Calcaterra M et al.
Thyroid : Official Journal of the American Thyroid Association, 2025
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection.
Sahm F et al.
Neuro-oncology, 2025
39577862 (PubMed )
Supplement: noae253_suppl_supplementary_materials.docx
The Molecular Landscape of 227 Adult Granulosa Cell Tumors of the Ovary: Insights into the Progression from Primary to Recurrence.
Michálková R et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology, 2025
Prognostic impact of genetic alterations and methylation classes in meningioma.
Berghoff AS et al.
Brain Pathology (zurich, Switzerland), 2022
35213082 (PubMed )
Supplement: BPA-32-e12970-s001.xlsx › Sheet1
AKT1E17K -mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363.
John P et al.
Neuropathology and Applied Neurobiology, 2022
Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.
Soares P et al.
Endocrine Pathology, 2021
Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?
Gomes-Lima CJ et al.
Frontiers in Endocrinology, 2021
Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas.
González-Tablas M et al.
Frontiers in Oncology, 2021
34868937 (PubMed )
Supplement: DataSheet_1.docx
Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case.
Stenman A et al.
Endocrine Pathology, 2020
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Pozdeyev N et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2018
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas.
Juratli TA et al.
Oncotarget, 2017
Select a paper to view details